Clinicians, including hematologists, are more frequently encountering transgender
individuals in practice; however, most lack training on the management and complications of …

Background Feminizing and masculinizing hormone treatments are established components
of management in transgender patients. Exogenous hormones have been associated with …

With the growing number of transgender and gender-nonbinary individuals who are
becoming visible, it is clear that there is a need to develop a rigorous evidence base to …

The medical care of transgender patients relies on the use of sex hormones to develop and
maintain the physical characteristics consistent with gender identity as the first step in …

Introduction Some providers report concern for the safety of transgender hormone therapy
(HT). Methods This is a systematic literature review of HT safety for transgender adults …

Context The effect of gender-affirming hormone therapy (HT) on erythropoiesis is an area of
priority in transgender health research. Objective To compare changes in hematologic …

Introduction: Venous thromboembolism (VTE) is a potential risk of estrogen therapy.
However, data show an improvement in the quality of life for transgender people who use …

Background Although venous thromboembolism (VTE) is a recognized side effect of some
formulations of estrogen therapy, its impact in transgender people remains uncertain. The …

METHODS: This retrospective chart review was conducted at a pediatric hospital-associated
transgender health clinic. The primary outcome was incidence of arterial or venous …

Gender affirming hormone therapy (GAHT) is used by many transgender people to reduce
gender incongruence and improve psychological functioning. As GAHT shares many …